News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
282 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26322)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (258)
2 (248)
3 (119)
4 (1)
5 (30)
6 (211)
7 (196)
8 (187)
9 (224)
10 (123)
11 (42)
12 (30)
13 (282)
14 (254)
15 (234)
16 (227)
17 (162)
18 (1)
19 (7)
20 (203)
21 (157)
22 (183)
23 (103)
24 (13)
25 (1)
27 (71)
28 (66)
29 (85)
30 (85)
31 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
Drug Development
Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual MeetingPreliminary Prexigebersen Data Show Signs of Safety and Efficacy in High Risk AML Patients
Bio-Path Holdings, Inc., (NASDAQ: BPTH), today announces a poster highlighting the safety and preliminary efficacy data of its Phase 2 study of prexigebersen (BP1001) was presented at the 2021 American Society of Hematology (ASH) Annual Meeting, taking place from December 11-14, 2021.
December 13, 2021
·
6 min read
Business
CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study
CareDx, Inc. today announced a partnership with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) organization to use their patient registry to evaluate the long-term impact of using AlloSure ® Kidney, for routine organ transplant surveillance in pediatric kidney patients.
December 13, 2021
·
4 min read
Deals
atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
atai Life Sciences N.V. today announced it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective as of market open on Monday, December 20, 2021.
December 13, 2021
·
5 min read
Drug Development
Q32 Bio Presents Preclinical Data Highlighting the Design and Characterization of Lead Program for Innate Immunity, ADX-097, at the 28th International Complement Virtual Workshop 2021
Q32 Bio today announced preclinical data for the Company’s lead program for innate immunity, ADX-097.
December 13, 2021
·
4 min read
Biotech Bay
Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021
Sutro Biopharma, Inc. today announced that its research collaborators at the Fred Hutchinson Cancer Research Center presented nonclinical data of STRO-002 and STRO-001 in two oral presentations at the 63rd American Society of Hematology Annual Meeting (ASH 2021) in Atlanta, Georgia.
December 13, 2021
·
7 min read
Business
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer
Nuvation Bio Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422, a cyclin-dependent kinase (CDK) 2/4/6 inhibitor, for the treatment of prostate cancer.
December 13, 2021
·
5 min read
Business
Henry Schein Expands Access to Point-of-Care Testing, PPE, and Essential Medical Supplies to Help Meet the Needs of Patients
Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has signed a cooperative contract with OMNIA Partners.
December 13, 2021
·
4 min read
Drug Development
4D Pharma Announces Positive Topline Results From Part a of Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma
4D pharma plc today announces positive topline results from Part A of phase I/II clinical trial of MRx-4DP0004, an orally-delivered single strain Live Biotherapeutic being developed for the treatment of asthma.
December 13, 2021
·
8 min read
FDA
InterVene’s BlueLeaf Endovenous Valve Formation (EVF) System Granted Breakthrough Device Designation by the FDA
InterVene Inc. announced today that it has received Breakthrough Device Designation by the FDA for the company’s BlueLeaf ® Endovenous Valve Formation System.
December 13, 2021
·
3 min read
Genetown
Intellia Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of NTLA-2002 for the Treatment of Hereditary Angioedema
Intellia Therapeutics, Inc. today announced that the first patient has been dosed with NTLA-2002, the company’s in vivo CRISPR/Cas9 genome editing candidate being developed as a single-dose therapy to prevent attacks in people living with hereditary angioedema (HAE).
December 13, 2021
·
6 min read
Previous
8 of 29
Next